StockData

Vanda Pharmaceuticals Inc. (VNDA) stock

VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3056% below fair value
$3.75−0.06 (-1.57%)

Close on Nov 18, 2026Market cap $226.76MP/E –Yield –

Vanda Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vanda Pharmaceuticals's market cap was $250.89M on Nov 11, 2026, against $316.75M a year earlier. Over the last 5 years it ranged from $207.11M to $874.07M, with a median of $326.46M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$250.89M-51.9%
2025Dec 31, 2025$521.22M+86.6%
2024Dec 31, 2024$279.29M+15.0%
2023Dec 29, 2023$242.77M-41.9%
2022Dec 30, 2022$418.19M-52.2%
2021Dec 31, 2021$874.07M+21.6%
2020Dec 31, 2020$718.62M-17.9%
2019Dec 31, 2019$875.20M-36.1%
2018Dec 31, 2018$1.37B+100.5%
2017Dec 29, 2017$682.83M-2.5%
2016Dec 30, 2016$700.69M+75.8%
2015Dec 31, 2015$398.61M-17.9%
2014Dec 31, 2014$485.46M+17.9%
2013Dec 31, 2013$411.89M+294.4%
2012Dec 31, 2012$104.44M-21.9%
2011Dec 30, 2011$133.81M-47.6%
2010Dec 31, 2010$255.56M–

More Vanda Pharmaceuticals figures

See a number that looks wrong?